chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Sep2022 at 09:30 as dose 5 (booster), single (Lot number: GH9702) at the age of 44 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 19Mar2021 as dose 1, single (Lot number: EN6207), in left arm, on 03Apr2021 as dose 2, single (Lot number: ER8734), in left arm, on 03Nov2021 at 15:45 as dose 3 (booster), single (Lot number: 32030BD) and on 29Mar2022 at 15:00 as dose 4 (booster), single (Lot number: FK9896), in left arm for covid-19 immunisation. The patient's relevant medical history included: "MS" (unspecified if ongoing); "Known allergies: seasonal allergies" (unspecified if ongoing), notes: Known allergies: seasonal allergies. Concomitant medication(s) included: JUNEL FE. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (02Dec2022) Negative, notes: Tested negative on day 9 of isolation; (05Dec2022) Positive, notes: Had positive test 05Dec; (10Dec2022) Positive, notes: am still testing positive on 10Dec. Therapeutic measures were taken as a result of drug ineffective, covid-19 (Paxlovid; Treatment start date: 25Nov2022, Treatment stop date: 29Nov2022).
Patient received 3rd dose of Pfizer COVID19 vaccination as booster 12/3/2021. (Schedule available in system w prior doses 3/19/2021, 2/26/2021). Developed shortness of breath 12/10 and later chest pain 12/15, presented to hospital and found to be having STEMI. Further workup likely catastrophic antiphospholipid syndrome as patient had arterial thrombotic events with STEMI require PCI and left arm, as well as venous thrombotic events with bilateral leg DVT and massive PE that required thrombectomy.
Initial report received on 04 Jun 2007 from a physician. A 17-year-old female patient with no medical conditions, no concurrent illnesses, not use of other medications, or known allergies had received a first, intramuscular, deltoid dose of Menactra (lot number unknown), on 04 June 2007. The site of administration was not reported. Within minutes of receiving the vaccination, the patient became dizzy and her blood pressure dropped into the 80s and she was pale. Her pulse was faint and slow. She had a brief twitching of her mouth that "appeared to be a seizure." The patient was placed in a supine position and the episode resolved after approximately 20 minutes with no treatment. The patient was observed for a full hour and experienced no further complaints.
received a shingles vaccine 3 years ago and did not receive the 2nd dose.; This case was reported by a other health professional via interactive digital media and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster Shingrix for prophylaxis.   Previously administered products included Shingrix (received 1st dose 3 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. Till the time of reporting patient did not receive 2nd dose of Shingrix which led to incomplete course of vaccination. The reporter verified that the patient received Shingrix. If so, could she still receive the 2nd dose. Follow up was not possible as no contact details were provided.
Fluzone QIV last injection administered in pregnancy with no reported adverse event; Initial information received  on 15-Sep-2022 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 37 years old female patient who was exposed to vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] in context of fluzone qiv last injection administered in pregnancy with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Fluzone QIV last injection administered in pregnancy with no reported adverse event occurred at 33 weeks of pregnancy and the patient was exposed to INFLUENZA QUADRIVAL A-B VACCINE at 33 weeks of pregnancy, during third pregnancy trimester for INFLUENZA QUADRIVAL A-B VACCINE.  The date of last menstrual period was reported as 26-Jan-2022. The estimated due date is 18-Nov-2022. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. The patient previous pregnancy was not reported.   On 14-Sep-2022, the patient received a dose one of suspect INFLUENZA QUADRIVAL A-B VACCINE at an unknown dose (lot UT7682KA, expiry date: not reported) via intramuscular route in unknown administration site for immunisation.  On 14-Sep-2022 the patient developed a non-serious fluzone qiv last injection administered in pregnancy with no reported adverse event (maternal exposure during pregnancy) same day following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Relevant prenatal testing after exposure not reported.  Action taken: Not applicable.  Outcome: Unknown   Additionally, at time of reporting, the pregnancy is still ongoing.
MMR given 4/07/09- she developed a rash on trunk 6 days later on 4/13/09-it was scattered over her upper trunk area- she called Employee Health on 4/17/09 stating the rash was transient and would come and go over different areas of her body- but was concentrated on trunk.  She described the rash as raised blister like without drainage.  She saw PCP on 4/17/09- was treated with zyrtec, prednisone and zantac.  4/29/09 continued to have symptoms-rash scattered over body- PCP felt she may be infectious- was held out of work until 05/05/09- when the hives cleared up and she came back to work.6/11/09 states hives came back - today mostly on legs- a few scattered over the abd. Saw allergist earlier in the week- taken off her meds- for allergy testing which was neg.  6/17/09 developed facial swelling and edema in mouth and throat- was admitted to hospital -started on high dose steroids and Plaquenil and diagnosed with vasculitis.  Is to be seen by Rhumatolgist. 6/22/09- denies any hives or itching.  7/30/09 Hospital records received DOS 6/17/09 6/19/09. Assessment: Urticarial vasculitis, viral induced vs underlying SLE. Angioedema, pruritis, hyponatremia and hyperglycemia. Patient presented with rash causing facial swelling and swelling of the lips, tongue and throat.  ICD-9 Codes: 708.9  995.1  287.0  276.1  E928.9  790.29  V58.69
Pt's first symptom was fever of 99 degrees the evening after vaccination. Fever resolved by the next day 10/31/2020. Pt woke up to leg/back muscle spasms on the right side of his body on 10/31/2020.  Spasms lasted until 11/3/2020 night. Pt says still has calf tightness but that has continued to improve.
Narrative: COVID infection following COVID vaccine series UNKNOWN DATE, Pfizer, dose #1 non-Facility UNKNOWN DATE Pfizer, dose #2 non-Facility 08/01 pt cc: exposure: unknown 08/11 COVID swab, result: detected
Very sore arm and fever that night while sleeping; stomach hurt for 3 days after getting vaccine. Did not seek medical care.
Fever and tired lasted 4-5 hours. I drank fluids and rested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old male patient received BNT162b2 (BNT162B2), on 10Mar2021 as dose 1, single (Batch/Lot number: unknown) and on 31Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 35 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (COVID-19 VACCINE MODERNA), on 06Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: my first positive test; Negative, notes: tested negative six days later. I subsequently remained negative for two more days; Positive, notes: On the third day my symptoms returned and I again tested positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: After the onset of symptoms and first positive test, took the full course of Paxlovid and tested negative six days later subsequently remained negative for two more days. On the third day  symptoms returned and again tested positive.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Generalized fatigue and weakness in conjunction of falls with in apartment in Assisted living. Family states that tenant had similar symptoms after receiving both doses of Moderna series earlier this year.
6 days (10/28/2021) after receiving my second dose of Pfizer I started to experience numbing sensation in my lower back when ever I looked down or moved my neck. Sensation went around to my torso. Thought I was having an MS attack so my PCP started me on steroids. Next day I woke up to numbness in my hands and finger tips. My face feels flushed and red constantly and my thighs feel as if they are 50 pounds each and I am having trouble walking at my normal speed. Also having issues holding things/ picking up items. I have been relapse free for 3 years now. I know this vaccine sent me into a relapse after all the hard work I did to keep myself stable. The government should be ashamed of themselves for forcing this vaccine on people who like me, who have an autoimmune disease. I was not ready to get this vaccine. It was too soon and now I am loosing feeling in parts of my body! Who Is going to be held responsible since I was forced into getting to keep my job!! This is beyond upsetting!!
About 12 hours after vaccine, patient had low grade fever of 100.6F, took Tylenol 1000mg, then BP dropped to 81/45 while laying flat.  During this time, patient had difficulty with vision due to seeing dark or black;  patient also felt nauseated during this time.  This lasted approximately one hour and seemed to improve once Tylenol kicked in and reduced fever.
The next morning after the vaccine I had severe body pain, fever and stiffness causing me to have to stay in the bed for about 3 days. Got dehydrated and had to drink plenty of fluids and around day 4 I wasn't as severe and was able to finally get out of bed and move around a bit. Every day after was up and down after that and around 8/22 a really nasty cough began to develop. The fever began coming and going and I lost my sense of taste and smell. I went to the ER on 8/29 because the symptoms got so bad, and the fever was 104 by that time. There a COVID-19 test was performed on myself and all 4 of my kids and the test came back positive for COVID-19. I was given the monoclonal infusion and a lung x-ray was performed to rule out pneumonia and was released and advised to quarantined for 21 days but eventually had to be quarantined for a total of 55 days d/t my symptoms lingering that full time.
I have been feeling light headed since I got the vaccine/I wouldn't call it dizzy but it feels like I could be dizzy; I wouldn't call it dizzy but it feels like I could be dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I have been feeling light headed since I got the vaccine/I wouldn't call it dizzy but it feels like I could be dizzy) and DIZZINESS (I wouldn't call it dizzy but it feels like I could be dizzy) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 007M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included DICLOFENAC, ALLOPURINOL, POTASSIUM CHLORIDE, INDAPAMIDE, AMLODIPINE, DEXLANSOPRAZOLE (DEXILANT) and ESCITALOPRAM for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (I have been feeling light headed since I got the vaccine/I wouldn't call it dizzy but it feels like I could be dizzy) and DIZZINESS (I wouldn't call it dizzy but it feels like I could be dizzy). The patient was treated with MECLIZINE [MECLOZINE] ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DIZZINESS (I have been feeling light headed since I got the vaccine/I wouldn't call it dizzy but it feels like I could be dizzy) had not resolved and DIZZINESS (I wouldn't call it dizzy but it feels like I could be dizzy) outcome was unknown. Not Provided
Swelling the size of an apple which lasted for 11 days Strong joint pain  left wrist and both knees still present 3 weeks after the injection  Throbbing pain in all past scars from surgeries including  my skull (40 years ago) abdominal sutures ( 6 years ago ) and right thigh ( 4years ago). The pain started within hours after the injection in scars which never hurt once they healed after the surgeries but now the pain is hard to bear. The strangest pain is the site of vein ablation in the right thigh where the tissue looked normal before but now it looks hollow and throbbing.
Patient was given a DTap when he was suppose to be given a Tdap. Patient did not have a side effect and was told that he did not need to come back for a Tdap because the DTap had the same amount of tetanus as the Tdap.
Pt reports she received her covid booster 4/25 @ approximately 1600. Pt reports she awoke at 0200 4/26 and hearing was completely gone in right ear. Pt seen by ENT and pt reports they suspect a vaccine reaction. Pt is being currently worked up by ENT to rule out other causes of sudden hearing loss.
Starting feeling "strange".  Itching all over, red splotchy areas over chest area.  Lips itchings, throat sore. Treated with Benadryl 50 mg IM.
This case involves a 77-years-old male patient who received an expired INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE QUADRIVALENT MULTIDOSE] (expired product administered). The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided. No concomitant medications were given to the patient. On 03-Nov-2021, the patient received a 0.5 mL dose of suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (once), (suspension for injection, lot UJ507AC, expiry date: 30-Jun-2021) via an unknown route at an unknown administration site for prophylactic vaccination. It was an actual medication error due to expired vaccine used (latency: same day). It was reported "The medical Information agent confirmed the spelling of demographics with the caller for accuracy. The caller reported that her facility orders Fluzone Quad directly from Sanofi and in their shipment of 2021-2022 product they received vials of 2020-2021. The caller reported that some staff and residents were administered the expired product and she wants to know what to do. A nurse reporting a medication error described as 20-staff members and 7-Residents received expired doses of FLUZONE QUADRIVALENT MDV from 2020-2021 year after receiving these 6-vials of the FLUZONE QUADRIVALENT MDV in the current years flu vaccine shipment. The nurse reported that the 20-staff members received the dose since the end of Oct2021; that the information on the staff members are not known, at the time of this report; that the staff has had no reports of adverse issues since dosing; that the 6-Residents received their dose on 03Nov2021; that the information for the residents is known to the reporter; that the residents have had no reports of adverse issues since dosing. The nurse reported that the doses came shipped to their central supply; that then the vaccines were distributed and placed in the vaccine refrigerators through the facility; that she is not the person that receives the vaccines from shipping and that she does not have the packaging slips or boxes due to it is handled with central supply; that when their staff is administering a vaccine the expiration date is not noted prior to administration; that the expiration date is not documented but just the LOT number; that the staff is not looking at the expiration date when administering; and that a nurse, yesterday, saw the expiration date to be expired after vaccinating residents." At time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module Regulatory Authority. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. This case is linked to cases 2021SA369738, 2021SA369789, 2021SA370183, 2021SA370209, 2021SA369806 and 2021SA371632 (CLUSTERS).
I have not had a menstrual cycle for 10 years, no spotting or anything. The day after getting vaccine I had slight bit of blood discharge. After the slight discharge it stopped and I feel good.
Was like hallucinating; A spontaneous report was received from a consumer, a 90 year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced was like hallucinating/hallucination.   The patient's medical history was not provided.  Concomitant product use was not provided.   On 09 Feb 2021, the same day of the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number: 013M20A) in the left arm for prophylaxis of COVID-19 infection.  After getting the vaccine, the patient had lunch and went home.  The patient arrived home two hours after receiving the vaccine and fell asleep.  When the patient opened her eyes after the nap, she saw her phone in front of her and reported the letters were moving as if she was writing; however, the patient reported that she was not even holding the phone and that the phone was still plugged in.  The patient stated, "I was like hallucinating".  Treatment for the event included was not reported.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Mother stated that day after shots child had a temp of 101.5, then 8 days after shots child broke out in red rash all over body. Rash not raised, child not complaining of any pain.
This spontaneous report was received from a nurse and refers to multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, concomitant medications, pertinent medical histories and drug reactions or allergies were not provided. On unknown dates, the patients received doses of improperly stored ZOSTAVAX vials of 19400 Plaque-Forming Units (PFU), lot # N009167 with expiration date on 02-FEB-2018 (doses and routes of administration were not reported). The nurse confirmed that the sterile diluent (manufacturer unknown) (unspecified lot # and expiration date) used to reconstitute the ZOSTAVAX was properly stored. Administered doses of vaccines underwent a temperature excursion from 15 degrees Fahrenheit to 46 degrees Fahrenheit, which lasted for 65 hours. There was no previous temperature excursion. A digital data logger was not involved in recording the excursion. No adverse effects were reported.
At 6:30 PM on day of vaccine he experienced dizzy spells off and on that lasted about 20 hours. Beginning about 10pm on date if vaccine he had flu like symptoms (aches, etc) for 24 Hours  48 hours after the time the vaccine was administered he developed hives around the injection site.
He got his vaccines, he came home and had no issues.  The next night he had diarrhea and vomiting.  Then he got rid of that and then the following day he started getting hives and itching and a rash on his legs and in his groin area, as well as his upper arms.  He went back to the pharmacy when the rash, hives and itching occurred and she gave him butenafine hydrochloride 1% cream.  It is helping a little bit, and if it doesn't go away after he gets done with this tube then he may go to his dermatologist.    He is feeling good otherwise and wants to know if people should be taking both of these together.  He is going to be hesitant regarding taking another vaccine.
S: while administering the vaccine, the needle came loose causing some medication to leak out B: Nurse feels that more than 1/2 of the vaccine went into the patient, per SHEMS the recommendation is to NOT revaccinate (but to submit a VAERS)
Injection site pain; Injection site redness; Injection site swelling; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE PAIN (Injection site pain), INJECTION SITE ERYTHEMA (Injection site redness) and INJECTION SITE SWELLING (Injection site swelling) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A.) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced INJECTION SITE PAIN (Injection site pain), INJECTION SITE ERYTHEMA (Injection site redness) and INJECTION SITE SWELLING (Injection site swelling). The patient was treated with BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE] for Injection site pain, Redness and Swelling, at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (Injection site pain), INJECTION SITE ERYTHEMA (Injection site redness) and INJECTION SITE SWELLING (Injection site swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient visit to the onsite nurse for reaction taken place.  No concomitant medication provided.
2 days after the injection i started getting real dizzy, i had to call someone cause i nearly passed out. they took me back to the office and let me sit there till someone came to relieve me. then i went home.  that was on Friday Jan 29, 2021. I stayed out of work for 3days, went  back to work on Mon Feb 1, 2021, still being dizzy i continued working till my days off on Wed Feb 3 and Thurs Feb 4,2021. went back to work Friday Feb 5,2021. had to leave work again because of severe dizzines.  Called immediately to see if i could get an appointment and got one Saturday Feb 6,2021.  then tried again to return to work again on a MondayFeb 8, 2021, worked through with vertigo again till days off Wed Thurs Feb 10 & 11,2021.  Tried to work again same thing on Fri Feb 12, 2021. Left work again and been out ever since.